DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

Biogen Idec

NASDAQ: BIIB

203.80 -7.00 (-3.32%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $203.80 -3.32%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $210.47
Previous Close $210.80
Daily Range $203.59 - $211.26
52-Week Range $134.00 - $242.64
Market Cap $48.4B
P/E Ratio 33.46
Dividend (Yield) $0.00 (0.0%)
Volume 1,201,689
Average Daily Volume 1,516,520
Current FY EPS $7.91

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

Why Coronado Biosciences Is Poised to Keep Plunging

Market-lagging returns could be written in this 2-Star.

Glaxo Gets Offer for Thrombosis Drugs - Analyst Blog

DaVita and Myriad Join Forces - Analyst Blog

Biogen Idec Inc (BIIB): Today's Featured Drugs Winner

Perrigo in Expansion Mode - Analyst Blog

Biogen's New Multiple Sclerosis Drug to Test Recent Stock Gains

Elan Explores Sale Options - Analyst Blog

Amgen Xgeva Label Expanded - Analyst Blog

Biotechs Lose Ground As Achillion Takes a Dive

Despite the biotech industry's strong year so far, leading stocks take a step back for the week.

Elan Is In Play

See More BIIB News...

BIIB's Top Competitors

BIIB $203.80 (-3.32%)
Current stock: BIIB
AMGN $99.18 (-2.29%)
Current stock: AMGN
GILD $50.60 (-2.58%)
Current stock: GILD
$0.00 (0.00%)
Current stock: